Treatment for cyclic mastodynia in patients with benign breast diseases
- Authors: Kravchenko E.N.1, Naboka M.V.1,2, Sosnin M.I.3, Tsygankova M.V.4
-
Affiliations:
- Omsk State Medical University, Ministry of Health of Russia
- Clinical Medical and Sanitary Unit No. 7
- Odintsovo Regional Hospital
- N.N. Petrov National Medical Research Center of Oncology, Ministry of Health of Russia
- Issue: No 3 (2024)
- Pages: 124-131
- Section: Exchange of Experience
- URL: https://journals.eco-vector.com/0300-9092/article/view/631629
- ID: 631629
Cite item
Open Access
Access granted
Abstract
Objective: To evaluate the efficacy of indole carbinol medication (Indinol Forto) in treating benign breast dysplasia (BBD).
Materials and methods: The study included 274 women aged 29–52 years who presented with complaints of breast pain: group A consisted of 109 women with BBD (BI-RADS 2) who were prescribed complex treatment with indole carbinol-based medication; group B included 79 patients with BBD (BI-RADS 3) who underwent surgery followed by complex treatment with indole carbinol-based medication; group C consisted of 86 women with BBD (BI-RADS 2) who refused to receive medical treatment.
Results: At the end of the six-month course of treatment with indole carbinol, there was a significant improvement in health and a decrease or disappearance of mastalgia: only 8.3% of women in group A (p1<0.001), 12.6% of women in group B (p2<0.001), and 76.7% of women in group C had complaints of mastodynia. Mild mammographic density was noted in 74.3% of patients in group A, in 72.3% of women in group B and in 46.5% of patients in group C (p1<0.001, p2<0.001); moderate density was noted in 20.1%, 19.0% and 32.6% of patients (p1=0.050, p2=0.048), respectively; severe density was noted in 3.7%, 3.8% and 12.8% of women (p1=0.018, p2=0.039), respectively; very severe density was noted in 1.8%, 1.3% and 8.1% of patients (p1=0.038, p2=0.041), respectively.
Conclusion: Indole carbinol medication may be recommended for widespread use as a first-line medication in women with increased breast density.
Full Text
About the authors
Elena N. Kravchenko
Omsk State Medical University, Ministry of Health of Russia
Author for correspondence.
Email: kravchenko.en@mail.ru
Dr. Med. Sci., Professor, Professor at the Department of Obstetrics and Gynecology No. 1
Russian Federation, OmskMaxim V. Naboka
Omsk State Medical University, Ministry of Health of Russia; Clinical Medical and Sanitary Unit No. 7
Email: nabokamax@mail.ru
Assistant, Department of Oncology, Radiation Therapy, oncologist at the Center for Outpatient Oncological Care
Russian Federation, Omsk; OmskMaxim I. Sosnin
Odintsovo Regional Hospital
Email: maxim.nervik@gmail.com
oncologist, Head of the Day Hospital of the Oncological Department of Drug Antitumor Therapy
Russian Federation, OdintsovoMaria V. Tsygankova
N.N. Petrov National Medical Research Center of Oncology, Ministry of Health of Russia
Email: tsygankovva98@mail.ru
2nd year clinical resident with a degree in oncology
Russian Federation, St. PetersburgReferences
- Каприн А.Д., Рожкова Н.И. Маммология. Национальное руководство. М.: ГЕОТАР-Медиа; 2016. 496 с. [Kaprin A.D., Rozhkova N.I. Mammology. National guide. Moscow: GEOTAR-Media; 2016. 496 p. (in Russian)].
- Рожкова Н.И., Бурдина И.И., Запирова С.Б., Мазо М.Л., Прокопенко С.П., Якобс О.Э. Своевременное лечение диффузных гиперплазий – профилактика рака молочной железы. Онкогинекология. 2016; 1: 4-11. [Rozhkova N.I., Burdina I.I., Zapirova S.B., Mazo M.L., Prokopenko S.P., Yakobs O.E. Timely treatment of diffuse hyperplasia – prevention of breast cancer. Oncogynecology. 2016; (1): 4-11. (in Russian)].
- Руженков В.А., Шуличенко Е.А. Психические расстройства у женщин с доброкачественной дислазией молочной железы. Современные проблемы науки и образования. 2016; 4: 52. [Ruzhenkov V.A., Shulichenko E.A. Mental disorders in women with benign breast dysplasia. Modern Problems of Science and Education. 2016; (4): 52. (in Russian)]. https://dx.doi.org/10.7752/jpes.2020.s1069.
- Керчелаева С.Б., Сметник А.А., Беспалов В.Г. Мастопатия и профилактика рака молочной железы как междисциплинарная проблема. РМЖ. Мать и дитя. 2016; 24(15): 1018-25. [Kerchelaeva S.B., Smetnik A.A., Bespalov V.G. Mastopathy and prevention of breast cancer as an interdisciplinary problem. breast cancer. RMJ. Mother and Child. 2016; 24(15): 1018-25. (in Russian)].
- Кравченко Е.Н., Ожерельева М.А. Состояние молочных желез при гинекологических заболеваниях (литературный обзор). Мать и дитя в Кузбассе. 2014; 2: 19-23. [Kravchenko E.N., Ozhereleva M.A. State of breast to the gynecological disease. Mother and Child in Kuzbass. 2014; (2): 19-23. (in Russian)].
- Сутурина Л.В. Современные подходы к оценке рисков и профилактике заболеваний молочной железы. Женское здоровье и репродукция. 2019; 9-10: 3-15. [Suturina L.V. Modern approaches to risk assessment and prevention of breast diseases. Women's Health and Reproduction. 2019; (9-101): 3-15. (in Russian)].
- Киселев В.И., Сметник В.П., Сутурина Л.В., Селиванов С.П., Рудакова Е.Б., Рахматуллина И.Р., Андреева Е.Н., Фадеева Н.И., Хасанов Р.Ш., Кулагина Н.В., Рожкова Н.И., Артымук Н.В., Гависова А.А., Муйжнек Е.Л., Кузнецов И.Н., Друх В.М. Индолкарбинол – метод мультитаргетной терапии при циклической мастодинии. Акушерство и гинекология. 2013; 7: 56-63. [Kiselev V.I., Smetnik V.P., Suturina L.V., Selivanov S.P., Rudakova E.B., Rakhmatullina I.R., Andreyeva E.N., Fadeyeva N.I., Khasanov R.Sh., Kulagina N.V., Rozhkova N.I., Artymuk N.V., Gavisova A.A., Muizhnek E.L., Kuznetsov I.N., Drukh V.M. Indole carbinol (Indinol Forto) is a multitargeted therapy option for cyclic mastodynia. Obstetrics and Gynecology. 2013; (7): 56-63. (in Russian)].
- Сметник В.П., Гависова А.А., Билак Н.П., Друх В.М. Эффективность индолкарбинола при циклической мастодинии. Проблемы репродукции. 2013; 5: 49-53. [Smetnik V.P., Gavisova A.A., Bilak N.P., Drukh V.M. Indolecarbinol efficacy for mastalgia treatment. Russian Journal of Human Reproduction. 2013; (5): 49-53. (in Russian)].
- Леваков С.А., Кавиладзе М.Г., Гелашвили А.З. Эффективность применения препарата индинол форто у пациенток с дисгормональными заболеваниями молочных желез. Фармакология & Фармакотерапия. 2022; 1: 90-94. [Levakov S.A., Kaviladze M.G., Gelashvili A.Z. The effectiveness of the drug Indinol forto in patients with dyshormonal diseases of the mammary glands. Pharmacology & Pharmacotherapy. 2022; (1): 90-4. (in Russian)]. https://dx.doi.org/10.46393/27132129_2022_1_90.
- Ашрафян Л.А., Бабаева Н.А., Антонова И.Б., Овчинникова О.А., Алешикова О.И., Моцкобили Т.А., Кузнецов И.Н. Уровень баланса эстрогенных метаболитов при раке молочной железы и пути его коррекции. Опухоли женской репродуктивной системы. 2015; 11(3): 22-9. [Ashrafyan L.A., Babaeva N.A., Antonova I.B., Ovchinnikova O.A., Aleshikova O.I., Motskobili T.A., Kuznetsov I.N. The balance of estrogen metabolites in breast cancer and the ways of its correction. Tumors of the female reproductive system. 2015; 11(3): 22-9. (in Russian)]. https://dx.doi.org/10.17650/1994-4098-2015-11-3-22-29.
- Хияева В.А. Опыт применения индолкарбинола при мастопатиях. Медицинский совет. 2019; 13: 154-8. [Khiyaeva V.A. Experience with indolecarbinol used to treat mastopathy. Medical Council. 2019; (13): 154-8. (in Russian)]. https://dx.doi.org/10.21518/2079-701X-2019-13-154-158.
- Тазина Т.В. Патогенетически обоснованная терапия циклической масталгии. Акушерство и гинекология. 2020; 9: 187-90. [Tazina T.V. Pathogenetically based therapy for cyclic mastalgia. Obstetrics and Gynecology. 2020; (9): 187-90. (in Russian)]. https://dx.doi.org/10.18565/ aig.2020.9.187-190.
- Кравченко Е.Н., Набока М.В. Лечение диффузных доброкачественных заболеваний молочной железы. Акушерство и гинекология. 2023; 2: 140-5. [Kravchenko E.N., Naboka M.V. Treatment for diffuse benign breast diseases. Obstetrics and Gynecology. 2023; (2): 140-5. (in Russian)]. https://dx.doi.org/10.18565/aig.2023.25.
- Тазина Т.В. Современный подход к терапии циклической масталгии у коморбидных пациенток. Акушерство и гинекология. 2021; 5: 158-64. [Tazina T.V. A modern approach to therapy for cyclic mastalgia in comorbid patients. Obstetrics and Gynecology. 2021; (5): 158-64. (in Russian)]. https://dx.doi.org/10.18565/aig.2021.5.158-164.
- Боровиков И.О., Куценко И.И., Булгакова В.П., Боровикова О.И. Негормональная терапия пациенток с фиброзно-кистозной мастопатией в сочетании с гиперплазией эндометрия. Медицинский совет. 2021; (21-1): 182-9. [Borovikov I.O., Kutsenko I.I., Bulgakova V.P.,Borovikova O.I. Non-hormonal therapy of patients with fibrocystic mastopathy in combination with endometrial hyperplasia. Medical Council. 2021; (21-1): 182-9. (in Russian)]. https://dx.doi.org/10.21518/2079-701X-2021-21-1-182-189.
Supplementary files
